Circulating Fibroblast Growth Factor 21 is Associated with Subsequent Renal Injury Events in Patients Undergoing Coronary Angiography

Fibroblast growth factor 21 (FGF21) is a regulator of glucose homeostasis, and is suggested to have protective effect on diabetic nephropathy. Its impact on non-diabetic kidney disease is unclear. To investigate the impact of FGF21 on contrast-induced nephropathy (CIN), 531 subjects underwent electi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Cheng-Hsueh, Chou, Ruey-Hsing, Kuo, Chin-Sung, Huang, Po-Hsun, Chang, Chun-Chin, Leu, Hsin-Bang, Huang, Chin-Chou, Chen, Jaw-Wen, Lin, Shing-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102249/
https://www.ncbi.nlm.nih.gov/pubmed/30127382
http://dx.doi.org/10.1038/s41598-018-30744-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102249/
https://www.ncbi.nlm.nih.gov/pubmed/30127382
http://dx.doi.org/10.1038/s41598-018-30744-8

Ejemplares similares